Fig. 2From: Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated resultsOverall survival of patients treated with AGI-101H re-induction in Trial 3 (a) and Trial 5 (b)Back to article page